LESLIE HIGGINS

S. 182/HR. 12 the Paycheck Fairness Act all provisions, regarding amending the Fair Labor Standards Act to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex and other purposes. HR. 1409/S. 560 the Employee Free Choice Act all provisions, regarding amending the National Labor Relations Act to establish a system that enables employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during organizing efforts.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

S. 182/HR. 12 the Paycheck Fairness Act all provisions, regarding amending the Fair Labor Standards Act to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex and other purposes. HR. 1409/S. 560 the Employee Free Choice Act all provisions, regarding amending the National Labor Relations Act to establish a system that enables employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during organizing efforts.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

H.R. 759 - the "Food and Drug Administration Globalization Act of 2009" - Title II - Drug and Device Safety - provisions relating to country of origin labeling for drugs and devices; H.R. 1815 the Consumer Product Safety Solutions Act Section 2 provisions relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provisions relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracking label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

Walgreens and its subsidiaries can impact efforts in health care reform with regards to access, affordability and quality. Senate Finance Policy Options Paper regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services, the role of nurse practioners, retail clinics and employer workite facilities in health care reform no specific legislation. American Health Choices Act draft health care reform legislation introduced by Senator Edward Kennedy; regarding expanding medication therapy management (MTM) services provided by pharmacists also the establishment of a grant program to implement MTM for the treatment of chronic diseases. House Tri-Committee Health Care Reform Draft regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), expanding home infusion in Medicare to cover the supplies, equipment and services, and regarding expanding medication therapy management (MTM) services provided by pharmacists. HR 2350 the Preserving Patient Access to Primary Care Act of 2009 all provisions; regarding increasing the number of primary care physicians and primary care providers, such as nurse practitioners and physician assistants, to improve patient access to primary care services.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

H.R. 759 - the "Food and Drug Administration Globalization Act of 2009" - Title II - Drug and Device Safety - provisions relating to country of origin labeling for drugs and devices; H.R. 1815 the Consumer Product Safety Solutions Act Section 2 provisions relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provisions relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracking label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S. 182/HR. 12 the Paycheck Fairness Act all provisions, regarding amending the Fair Labor Standards Act to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex and other purposes. HR. 1409/S. 560 the Employee Free Choice Act all provisions, regarding amending the National Labor Relations Act to establish a system that enables employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during organizing efforts.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR. 1173 the Organized Retail Crime Act of 2009 all provisions, regarding amending title 18 of the United States Criminal Code to include organized retail crime and imposing requirements on on-line marketplaces to facilitate criminal investigations. S. 470 the Combating Organized Retail Crime Act of 2009 all provisions, regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace. HR. 1166 the E-Fencing Enforcement Act of 2009 all provisions, regarding amending the criminal code to impose duty on on-line marketplaces to retain contact information on high volume sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.

H.R. 1173 the Organized Retail Crime Act of 2009 all provisions, regarding amending title 18 of the United States Criminal Code to include organized retail crime and imposing requirements on on-line marketplaces to aid in criminal investigations; S. 470 the Combating Organized Retail Crime Act of 2009 all provisions, regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 1166 the E-Fencing Enforcement Act of 2009 all provisions, regarding amending the criminal code to impose duty on on-line marketplaces to retain contact information on high volume sellers and disclose that information when evidence is presented by law enforcement regarding stolen merchandise.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

S. 182/HR. 12 the Paycheck Fairness Act all provisions, regarding amending the Fair Labor Standards Act to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex and other purposes. HR. 1409/S. 560 the Employee Free Choice Act all provisions, regarding amending the National Labor Relations Act to establish a system that enables employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during organizing efforts.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

S. 1276/H.R. 2747 the "Methamphetamine Production Prevention Act of 2007" - electronic logbooks, tracking systems; H.R. 3610 the "Food and Drug Import Safety Act of 2007" - Sec. 6 regarding country of origin labeling for drugs and devices; S. 2274 the "Dextromethrophan Abuse Reduction Act of 2007" - regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the "Consumer Product Safety Commission Reform Act of 2007" - Sec. 23 (e) regarding the implementation of new lead standards; S. 1693 the "Wired for Healthcare Quality Act of 2007" Title IV, Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; House HIT discussion draft regarding changes to the definition of marketing under HIPAA, breach notification and accounting of electronic disclosures.

S.1276/H.R. 2747 Methamphetamine Production Prevention Act of 2007 regarding electronic logbooks and tracking systems for pseudoephedrine; H.R. 3610 Food and Drug Import Safety Act of 2007 Sec. 6 regarding country of origin labeling for drugs and devices; S. 2274 Dextromethrophan Abuse Reduction Act of 2007 regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2274 Dextromethrophan Abuse Reduction Act of 2007 regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the Consumer Product Safety Commission Reform Act of 2007 Sec. 23 (e) regarding the implementation of new lead standards.

S. 1276/H.R. 2747 the "Methamphetamine Production Prevention Act of 2007" - electronic logbooks, tracking systems; H.R. 3610 the "Food and Drug Import Safety Act of 2007" - Sec. 6 regarding country of origin labeling for drugs and devices; S. 2274 the "Dextromethrophan Abuse Reduction Act of 2007" - regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the "Consumer Product Safety Commission Reform Act of 2007" - Sec. 23 (e) regarding the implementation of new lead standards; H.R. 1108 the "Family Smoking Prevention and Tobacco Control Act" Title I, Chapter IX Sec. 913 regarding equal treatment of retail outlets and Sec 917 regarding preservation of state and local authority.

S. 1276/H.R. 2747 Methamphetamine Production Prevention Act of 2007 regarding electronic logbooks and tracking systems for pseudoephedrine; H.R. 3610 Food and Drug Import Safety Act of 2007 Sec. 6 regarding country of origin labeling for drugs and devices; S. 2045 the Consumer Product Safety Commission Reform Act of 2007 Sec. 23 (e) regarding the implementation of new lead standards.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 3101 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 the "E-Meds Act of 2007" regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" - Sec. 514 regarding anti-counterfeiting technology, Sec. 807 regarding internet pharmacy; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety; H.R. 5839 the "Safeguarding America's Pharmaceuticals Act of 2008" regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; H.R. 5658 the "Duncan Hunter National Defense Authorization Act for Fiscal Year 2009" - Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides - regarding improvements needed to the Medication Guide program - no specific legislation.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.

H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.

H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period

H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 154 regarding a delay in the competitive acquisition program for DME

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 3101 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 the "E-Meds Act of 2007" regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" - Sec. 514 regarding anti-counterfeiting technology, Sec. 807 regarding internet pharmacy; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety; H.R. 5839 the "Safeguarding America's Pharmaceuticals Act of 2008" regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; H.R. 5658 the "Duncan Hunter National Defense Authorization Act for Fiscal Year 2009" - Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides - regarding improvements needed to the Medication Guide program - no specific legislation.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 3101 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 the "E-Meds Act of 2007" regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" - Sec. 514 regarding anti-counterfeiting technology, Sec. 807 regarding internet pharmacy; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety; H.R. 5839 the "Safeguarding America's Pharmaceuticals Act of 2008" regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; H.R. 5658 the "Duncan Hunter National Defense Authorization Act for Fiscal Year 2009" - Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides - regarding improvements needed to the Medication Guide program - no specific legislation.

S. 1276/H.R. 2747 the "Methamphetamine Production Prevention Act of 2007" - electronic logbooks, tracking systems; H.R. 3610 the "Food and Drug Import Safety Act of 2007" - Sec. 6 regarding country of origin labeling for drugs and devices; S. 2274 the "Dextromethrophan Abuse Reduction Act of 2007" - regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the "Consumer Product Safety Commission Reform Act of 2007" - Sec. 23 (e) regarding the implementation of new lead standards; S. 1693 the "Wired for Healthcare Quality Act of 2007" Title IV, Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; House HIT discussion draft regarding changes to the definition of marketing under HIPAA, breach notification and accounting of electronic disclosures.

S.1276/H.R. 2747 Methamphetamine Production Prevention Act of 2007 regarding electronic logbooks and tracking systems for pseudoephedrine; H.R. 3610 Food and Drug Import Safety Act of 2007 Sec. 6 regarding country of origin labeling for drugs and devices; S. 2274 Dextromethrophan Abuse Reduction Act of 2007 regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2274 Dextromethrophan Abuse Reduction Act of 2007 regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the Consumer Product Safety Commission Reform Act of 2007 Sec. 23 (e) regarding the implementation of new lead standards.

S. 1276/H.R. 2747 the "Methamphetamine Production Prevention Act of 2007" - electronic logbooks, tracking systems; H.R. 3610 the "Food and Drug Import Safety Act of 2007" - Sec. 6 regarding country of origin labeling for drugs and devices; S. 2274 the "Dextromethrophan Abuse Reduction Act of 2007" - regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the "Consumer Product Safety Commission Reform Act of 2007" - Sec. 23 (e) regarding the implementation of new lead standards; H.R. 1108 the "Family Smoking Prevention and Tobacco Control Act" Title I, Chapter IX Sec. 913 regarding equal treatment of retail outlets and Sec 917 regarding preservation of state and local authority.

S. 1276/H.R. 2747 Methamphetamine Production Prevention Act of 2007 regarding electronic logbooks and tracking systems for pseudoephedrine; H.R. 3610 Food and Drug Import Safety Act of 2007 Sec. 6 regarding country of origin labeling for drugs and devices; S. 2045 the Consumer Product Safety Commission Reform Act of 2007 Sec. 23 (e) regarding the implementation of new lead standards.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 3101 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 the "E-Meds Act of 2007" regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" - Sec. 514 regarding anti-counterfeiting technology, Sec. 807 regarding internet pharmacy; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety; H.R. 5839 the "Safeguarding America's Pharmaceuticals Act of 2008" regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; H.R. 5658 the "Duncan Hunter National Defense Authorization Act for Fiscal Year 2009" - Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides - regarding improvements needed to the Medication Guide program - no specific legislation.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 3101 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 the "E-Meds Act of 2007" regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" - Sec. 514 regarding anti-counterfeiting technology, Sec. 807 regarding internet pharmacy; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety; H.R. 5839 the "Safeguarding America's Pharmaceuticals Act of 2008" regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; H.R. 5658 the "Duncan Hunter National Defense Authorization Act for Fiscal Year 2009" - Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides - regarding improvements needed to the Medication Guide program - no specific legislation.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.

H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 3101 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDP's and MA-PD's for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 the "E-Meds Act of 2007" regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" - Sec. 514 regarding anti-counterfeiting technology, Sec. 807 regarding internet pharmacy; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety; H.R. 5839 the "Safeguarding America's Pharmaceuticals Act of 2008" regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; H.R. 5658 the "Duncan Hunter National Defense Authorization Act for Fiscal Year 2009" - Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides - regarding improvements needed to the Medication Guide program - no specific legislation.

H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 154 regarding a delay in the competitive acquisition program for DME

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

H.R. 6491 Organized Retail Crime Act of 2008 regarding amending title 18 of the U.S. Criminal Code to include organized retail crime and imposing requirements on "on-line" marketplaces to facilitate criminal investigations; S. 3434 Combating Organized Retail Crime Act of 2008 regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 6713 the E-Fencing Enforcement Act of 2008, regarding amending the criminal code to impose duty on "on-line" marketplaces to retain contact information on "high volume" sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.

H.R. 6491 Organized Retail Crime Act of 2008 regarding amending title 18 of the U.S. Criminal Code to include organized retail crime and imposing requirements on "on-line" marketplaces to facilitate criminal investigations; S. 3434 Combating Organized Retail Crime Act of 2008 regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 6713 the E-Fencing Enforcement Act of 2008, regarding amending the criminal code to impose duty on "on-line" marketplaces to retain contact information on "high volume" sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.

H.R. 6491 Organized Retail Crime Act of 2008 regarding amending title 18 of the U.S. Criminal Code to include organized retail crime and imposing requirements on "on-line" marketplaces to facilitate criminal investigations; S. 3434 Combating Organized Retail Crime Act of 2008 regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 6713 the E-Fencing Enforcement Act of 2008, regarding amending the criminal code to impose duty on "on-line" marketplaces to retain contact information on "high volume" sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.

H.R. 6491 Organized Retail Crime Act of 2008 regarding amending title 18 of the U.S. Criminal Code to include organized retail crime and imposing requirements on "on-line" marketplaces to facilitate criminal investigations; S. 3434 Combating Organized Retail Crime Act of 2008 regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 6713 the E-Fencing Enforcement Act of 2008, regarding amending the criminal code to impose duty on "on-line" marketplaces to retain contact information on "high volume" sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.